MEDANTA
Big movers on D-Street: What should investors do with Emami, CDSL and Medanta?
Benchmark Sensex and Nifty hit record highs fueled by global market gains. Emami shows bullish breakout potential while CDSL faces profit booking risk. Medanta's surge warns of a distribution phase, urging caution for new buyers until confirmation near 1388 levels.
Fortis, Apollo, Medanta, and Max lead the charge in bidding war for Jaypee Healthcare
Fortis Healthcare, Apollo Hospitals, Medanta, and Max Healthcare are among companies interested in acquiring Jaypee Healthcare, a subsidiary of Jaypee Infratech in Noida with a total debt of about Rs 1,000 crore.
Stocks with tailwinds called advantage India: 5 largecap stocks from 3 different sectors with an upside potential of upto 36 %
In terms of valuations and sentiment we are not far from the place where we were in the last quarter of 2023 or early part of this year. When it was not possible to find stocks which can be called as “fairly valued” forget “undervalued”, and the sentiment was very bullish. The only difference between then and now is that we have election results which are coming up. Surely a confirmation on 4th June that continuity in the policy making is a big factor. But there is another thing which long term investors need to look at before investing. Whether the company or the sector has an advantage due to India as a country. A well known example, which has been present for decades is that of the IT industry. India as a country is a factory of software engineers, and that is our strength. So when investing for the long term, look at sectors where we have some strong tailwinds due to our human capital.
New study warns of serious side effects from popular weight loss drugs Wegovy and Ozempic, finds they may paralyse stomach
A recent US study has found that weight loss medications like Wegovy and Ozempic may increase the risk of abdominal paralysis, characterized by delayed stomach emptying. The study, presented at Digestive Disease Week 2024, indicates a 30% higher risk for users of these drugs. Experts emphasize the need for awareness and medical monitoring of potential gastrointestinal side effects.
What to do with Zomato, Cochin Shipyard and 4 other stocks? Aamar Deo of Angel One decodes
Ahead of the June 4 general election, India VIX nears 30, causing high volatility. Analyst advises caution in investing light amid market rally driven by Modi and Amit Shah's statements. RBI's record dividend payout boosts market sentiments. Watch Nifty and Bank Nifty levels for market trends. Consider diversifying among large caps, midcaps, and small caps.
Medanta management on business performance, growth outlook and more
So, on an overall basis, we are very happy with how things are going. This is in line with our stated strategy of making sure we focus on quality, driving growth through volume.
- Go To Page 1
Global Health Q4 Results: Net profit rises 25% to Rs 127 crore
For the year ended on March 31, 2024, the company said its net profit increased to Rs 478 crore as against Rs 326 crore in FY23.
Medanta Q4 Results: Net profit jumps 26% YoY to Rs 127.3 crore
Global Health (Medanta) reported 26% year-on-year (YoY) jump in net profit to Rs 127.3 crore in Q4FY24 due to increase in revenue growth from matured and new hospitals, along with higher patient volumes.
Migsun group to invest Rs 500 crore across four projects in Greater Noida
Realty developer Migsun Group plans to invest Rs 500 crore in four mixed-use commercial projects covering 2 million sq ft, with RERA approval. Three projects are in Yamuna Expressway and one in Greater Noida, set for completion by 2028. Funding will come from company sources and customer advances, targeting the upcoming Jewar Airport to boost development. MD Yash Miglani asserts a commitment to bring international experiences to the Noida Expressway region. Additionally, the group has launched a mix-use project in Lucknow, investing Rs 426 crore on a 5-acre land parcel acquired from Medanta Group.
Do you work night shifts? Here's what you need to know about the risks
A study by scientists at Washington State University and the Pacific Northwest National Laboratory reveals the detrimental effects of working night shifts on health. Volunteers underwent simulated night or day shifts for three days to assess internal biological rhythms, published in Proteome Research.
Anand Rathi initiates coverage on 6 hospital stocks with upside potential of up to 25%
Anand Rathi initiates coverage on 6 hospital stocks, recommending 'buy' for Max Healthcare, Rainbow Children’s Medicare, KIMS, and Jupiter Life-Line Hospitals, while suggesting 'hold' for Global Health (MEDANTA) and Narayana Hrudayalaya. They cite India's healthcare market potential, driven by demographic changes and non-communicable diseases, forecasting 15% CAGR to Rs 7.7 lakh crore by FY25.
Max Healthcare readies Rs 5,500-crore outlay for capacity expansion
Max Healthcare has 4,000 beds, mainly concentrated in Delhi NCR. Of the fresh capacity, about 2,600 beds will become available over the next four years. The hospital chain is planning to open 300 beds in Delhi shortly besides commissioning 1,000 beds each in FY25 and FY26.
Migsun Group to invest Rs 426 crore on mix-use project in Lucknow
"This is our second commercial project in Lucknow," said Yash Miglani, managing director of Migsun Group. "Our first project, Migsun Janpath, is also successful, and the prices have appreciated almost two-fold. We hope to repeat this performance again with Migsun Central."
Realty developer Migsun buys land from Medanta in Lucknow, to develop a commercial project
The builder said it will develop about 800,000 sq ft of mix of retail and serviced apartment, with a total investment of Rs 426 crore, which includes the land cost as well.
Why pure RO drinking water is not healthy for you: Doctors, WHO raise health warning
Experts warn against the prevailing belief that RO filtered water is healthiest, highlighting health risks due to mineral depletion. Maintaining TDS levels of 200-250 mg/L is crucial, retaining essential minerals. WHO and health professionals caution against excessive RO use. Adverse effects in countries like Czechoslovakia and Slovakia due to mineral deficiencies are noted. Regulatory bodies emphasize the need for oversight to ensure balanced water purification methods.
Private hospitals say standardising rates will be catastrophic for sector
Private hospitals express apprehensions over Supreme Court intervention to curb charges. There is wide variation in treatment cost between government and private healthcare facilities. Association of Healthcare Providers has raised concerns and urged Health Ministry to address the categorisation of establishments.
Medanta shares jump 14%, hit fresh 52-week high on strong Q3 show
The rally has been more pronounced since the company announced its December quarter earnings on Thursday where reported a consolidated PAT of Rs 123.50 crore which was up by 53% YoY. PAT margins increased from 11.4% in Q3 FY23 to 14.5% in Q3 FY24, the company filing said.
Medanta stock turning a multibagger makes founder Naresh Trehan a billionaire
The 4% gains on Thursday turned shares of the hospital chain operator into a multibagger. The stock has given 104% returns so far in 2023.
Rohit Bal 'critical' following cardiac complications, fashion designer on ventilator: Report
Hospital sources have said that the designer was admitted following complications due to dilated cardiomyopathy.
Medanta reports 46% jump in net profit to Rs 125 crore in Q2FY24
The earnings before interest, tax, depreciation and ammortisation (EBITDA) rose 35.7% YoY to Rs 234 crore. The EBITDA margins expanded 220 basis points YoY to 27%.
Fundamental Radar: Why Global Health deserves premium valuation vs sector? Sneha Poddar explains
Medanta is a leading tertiary care service provider, with established presence in north and east India. It has built its hospitals network in Gurugram, Indore, Ranchi, Lucknow, Patna, and Noida.
Hot Stocks: Brokerage view on L&T, ICICI Lombard, RIL and Medanta
CLSA maintained a buy rating on ICICI Lombard with a target price of Rs 1550. Motor segment is picking up momentum with each passing month.
Do you misplace items, forget names? It could be 'pseudo-dementia'
Pseudo-dementia, a condition characterized by cognitive impairments caused by depression or stress, is increasingly affecting younger individuals. It is not a progressive illness like dementia and does not result in brain degeneration. Factors such as excessive stress, multitasking, and heavy workloads contribute to this condition. Counseling, cognitive-behavioral therapy, and relaxation techniques have been effective in managing pseudo-dementia. Awareness and support are crucial in helping individuals address this emerging challenge.
Jharkhand Mukti Morcha supremo Shibu Soren hospitalised in Delhi
The chief minister later returned to Ranchi from where he was to fly to Hazaribag to attend a function but could not do so after his helicopter developed a technical snag, officials said.
Medanta Q1 Results: Net profit soars 74% YoY to Rs 102 crore
The earnings before interest, tax, depreciation and ammortisation (EBITDA) rose 40.7% YoY to Rs 199 crore. The EBITDA margins expanded 250 basis points YoY to 25.1%
DLF, Medanta form SPV to develop hospital in south Delhi
DLF has partnered with Global Health to build a 400-bed hospital in South Delhi's Greater Kailash, marking the company's entry into the healthcare sector. Medanta will run the hospital while DLF acts as the strategic investor.
Medanta ties-up with GE HealthCare to launch digital ICU services
Medanta, the hospital chain operated by Global Health in association with GE HealthCare to launch the Medanta e-ICU, which aims to provide advanced tele-ICU services in India. The initiative will enable 24/7 staffed Medanta e-ICU command centres equipped with technology from GE HealthCare for remote patient monitoring, allowing early interventions that improve clinical outcomes.
Medanta sees new hospitals & services, complex specialities boosting margins
Medanta chairman Naresh Trehan said there is a shift in trend from Covid-19 years, as there is less contribution from internal medicine and an increase in cases from complex specialities.
Load More
